Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Angewandte Chemie (International Ed. in English)|April 17, 2025
Robust Tunnel TaOx Passivating Interlayer Enables Long-Term Solar Water OxidationYuanqi Wang, Yinglei Zhu, Lijuan Zhang, et al.
Stem Cells and Development|December 29, 2020
Dose- and Time-Dependent Effects of Human Mesenchymal Stromal Cell Infusion on Cardiac Allograft Rejection in MiceFeng Wang, Xiaoyong Chen, Jun Li, et al.
Journal of the American Chemical Society|September 18, 2025
Methyl Radical Dominated Highly Selective Methane Oxidation to Liquid OxygenatesJingwen Jiang, Zhonghua Li, Wangxi Liu, et al.
Frontiers in Medicine|December 17, 2020
Plasma Soluble CD146 as a Potential Diagnostic Marker of Acute Rejection in Kidney TransplantationJun Liao, Qian Fu, Wenfang Chen, et al.
Frontiers in Immunology|March 19, 2020
Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational StudyHuanxi Zhang, Chunting Zheng, Xirui Li, et al.
Virologica Sinica|January 26, 2017
Molecular epidemiology demonstrates that imported and local strains circulated during the 2014 dengue outbreak in Guangzhou, ChinaGeng Li, Pan Pan, Qiuyan He, et al.
Nature Communications|February 23, 2023
Renewable formate from sunlight, biomass and carbon dioxide in a photoelectrochemical cellYuyang Pan, Huiyan Zhang, Bowen Zhang, et al.
International Immunopharmacology|April 10, 2024
Machine learning-based integration develops a stress response stated T cell (Tstr)-related score for predicting outcomes in clear cell renal cell carcinomaShuai Yang, Zhaodong Han, Zeheng Tan, et al.
Frontiers in Immunology|May 2, 2022
Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic ValueShenghui Wu, Xiaojun Su, Qianyu Ye, et al.
Frontiers in Immunology|July 12, 2021
Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II StudyYongcheng Wei, Xiaoyong Chen, Huanxi Zhang, et al.
Pageof 8